破裂性胸主动脉瘤TEVAR术后长期结局
本研究在大规模学术医疗中心回顾2005至2022年所有因破裂性胸主动脉瘤(rTAA)和择期完整胸主动脉瘤(iTAA)行TEVAR的病例,比较长期生存与再干预。rTAA占321例TEVAR的20%(65/321),中位随访5.1年。rTAA患者30天生存(69.2% vs 96.9%,P < .001)及1、5、8年生存均更差,但存活≥90天者8年生存差异极小(34% vs 33%,log-rank P = .43)。
要点
- rTAA占全部TEVAR的20%(65/321),30天生存显著低于iTAA(69.2% vs 96.9%,P < .001)。
- rTAA总体1年生存46% vs iTAA 86%,5年27% vs 48%,8年20% vs 32%。
- 存活≥90天的rTAA患者8年生存与iTAA相近(34% vs 33%,log-rank P = .43)。
核心结论
- rTAA患者短期结局较iTAA差,但存活超过90天者长期生存与iTAA相当。
- rTAA早期死亡率高是总体长期生存差异的主要驱动因素。
研究设计与样本
- 回顾性分析单中心2005至2022年所有因rTAA和iTAA行TEVAR的321例患者。
- 长期临床结局观察至8年,rTAA占20%(65/321),中位临床随访5.1年。
主要发现
- rTAA组30天生存69.2% vs iTAA组96.9%(P < .001),卒中、肺炎和延长通气发生率更高(均P ≤ .01)。
- rTAA组总体1年生存46% vs iTAA组86%,5年27% vs 48%,8年20% vs 32%(均P < .001)。
- 存活≥90天者8年生存rTAA组34% vs iTAA组33%(log-rank P = .43)。
- rTAA组30天内再干预更多,晚期再干预率相当,I型内漏为主要原因。
关键数值与推荐
- rTAA患者30天生存69.2%,iTAA患者96.9%(P < .001)。
- rTAA患者1年生存46%、5年27%、8年20%,iTAA患者分别为86%、48%、32%(均P < .001)。
- 存活≥90天者8年生存rTAA组34% vs iTAA组33%(log-rank P = .43)。
临床怎么用
- rTAA急诊TEVAR后早期死亡风险高,需加强围术期管理。
- 存活超过90天的rTAA患者长期生存与择期iTAA相当,提示度过早期高风险期后长期预后可接受。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limited data exist on long-term mortality and reintervention rates after emergent thoracic endovascular aortic repair (TEVAR) for ruptured thoracic aortic aneurysm (rTAA). This study aimed to characterize the long-term outcomes of emergent TEVAR for rTAA. METHODS: All TEVARs for rTAA and elective intact thoracic aortic aneurysms (iTAAs) were reviewed at a large academic medical center from 2005 to 2022. Long-term clinical outcomes were considered over eight years. RESULTS: Of 321 patients undergoing TEVAR for TAA, 20% (65/321) presented with rTAA. Median clinical follow-up was 5.1 years. rTAA patients had much lower 30-day survival (69.2% vs 96.9%; P < .001) and higher rates of stroke, pneumonia, and prolonged ventilation (all P ≤ .01). Long-term survival was worse for all rTAA patients compared to all iTAA patients at 1 year (46% vs 86%), 5 years (27% vs 48%), and 8 years (20% vs 32%; all P < .001), driven largely by frequent early mortality. However, for patients surviving at least 90 days, the long-term survival difference over 8 years was minimal (34% vs 33%, log-rank P = .43) among patients presenting with ruptured vs intact TAA. Ruptured aneurysms required more reinterventions within 30 days, but had comparable late reintervention rates, with type I endoleak as the leading cause. CONCLUSIONS: The present study is the largest to focus on long-term outcomes following TEVAR for rupture TAA. Unsuprisingly, short-term outcomes are worse in patients presenting with ruptured vs intact aneurysms. However, importantly, long-term survival in rTAA patients who do survive 90 days is comparable to that of iTAA patients.
引用
- Fiandeiro M, Goel NJ, Mosbahi S, et al. Longitudinal outcomes of thoracic endovascular aortic repair for ruptured thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2024. PMID: 39019151. doi:10.1016/j.jtcvs.2024.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。